• OPEN AN ACCOUNT
Indian Indices
Nifty
17,080.70 129.00
(0.76%)
Sensex
57,960.09 346.37
( 0.60%)
Bank Nifty
39,910.15 342.25
( 0.86%)
Nifty IT
28,011.30 308.55
( 1.11%)
Global Indices
Nasdaq
11,926.24 210.16
(1.79%)
Dow Jones
32,717.60 323.35
(1.00%)
Hang Seng
20,309.13 116.73
(0.58%)
Nikkei 225
27,782.93 -100.85
(-0.36%)
Forex
USD-INR
82.23 -0.09
(-0.10%)
EUR-INR
89.03 0.31
(0.35%)
GBP-INR
101.31 0.39
(0.38%)
JPY-INR
0.63 0.00
(0.20%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
291.7616653
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
25.9
71662.87
EPS(TTM)
Face Value()
Div & Yield %
34.28
2
0.56
 

cipla ltd
Cipla Ltd - Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended 31St December 2022
Jan 25,2023
The Board of Directors of the Company at its meeting held today i.e. 25th January 2023 has inter-alia approved the unaudited financial results (standalone and consolidated) for the quarter and nine months ended 31st December 2022. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed as follows: (1) Unaudited financial results (standalone and consolidated) as per Indian Accounting Standards for the quarter and nine months ended 31st December 2022; and (2) Limited review report (standalone and consolidated) by Walker Chandiok & Co LLP Statutory Auditor of the Company for the quarter and nine months ended 31st December 2022. The meeting of the Board of Directors of the Company commenced at 10.30 a.m. (IST) and is still in progress.